The Validity of Surrogate Endpoints in Sub Groups of Metastatic Colorectal Cancer Patients Defined by Treatment Class and KRAS Status. (2022)
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.3390/cancers14215391
PubMed Identifier: 36358810
Publication URI: http://europepmc.org/abstract/MED/36358810
Type: Journal Article/Review
Volume: 14
Parent Publication: Cancers
Issue: 21
ISSN: 2072-6694